TIMOTHY R PEARSON
CIK 1528617 · Exec. VP, CFO · last filed 2026-06-11
TIMOTHY R PEARSON is an Exec. VP, CFO who has filed 28 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for KRRO, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$373.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
28
-$373.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | Director | — | $11.61 | — | $0 | 3 | 2026-06-11 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 24,650 | $15.70 | $387.0K | $25.0K | 12 | 2024-05-01 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | — | — | — | $0 | 4 | 2020-04-03 |
| TESARO, Inc. (TSRO) Delisted | Exec. VP, CFO | 0 | — | — | -$398.3K | 5 | 2019-01-22 |
| CATALYST HEALTH SOLUTIONS, INC. (CHSI) Delisted | EVP & Chief Financial Officer | 40,000 | — | — | $0 | 2 | 2012-02-27 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | KRRO | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | KRRO | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | KRRO | Grant (A) | — | $0 | EDGAR |
| 2024-05-01 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-07 | — | Grant (A) | — | $0 | |
| 2023-05-22 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-14 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Buy (P) | +19,400 | $25.0K | EDGAR |
| 2022-05-20 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-27 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | +5,250 | $0 | EDGAR |
| 2020-05-27 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |